(Q39834282)

15 September 2017

In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus (English)

1 reference

methicillin-resistant Staphylococcus aureus

15 September 2017

0 references

Staphylococcus aureus

1 reference

Alvarez S

1

1 reference

15 September 2017

Jones M

series ordinal

2

1 reference

15 September 2017

Berk SL

series ordinal

3

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 November 1985

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

5

1 reference

15 September 2017

689-690

1 reference

Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

The mechanism of action of fosfomycin (phosphonomycin)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

Bacteriological evaluation of fosfomycin in clinical studies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

[Comparison of activity of fosfomycin, oxacillin and penicillin G against staphylococci and micrococci (author's transl)]

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

Antimicrobial activity of fosfomycin in vitro.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176358

Vancomycin therapy for methicillin-resistant Staphylococcus aureus

20 August 2018

1 reference

12 December 2020

International recognition of methicillin-resistant strains of Staphylococcus aureus

1 reference

12 December 2020

International collaborative study on standardization of bacterial sensitivity to fosfomycin

1 reference

12 December 2020

Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.28.5.689

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

3853963

1 reference